Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

NCT06857344 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2025-08-15

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the performance difference between trained model and clinical professionals in anesthesia control during gastrointestinal endoscopy. The participants would include adults aged between 18-65 years old with ASA scores I-II. The main questions it aims to answer are:

* Can AI model successfully and safely perform anesthesia during gastrointestinal endoscopy?
* Researchers hypothesis that anesthesia performed by professionals is not inferior to those performed by AI model.

The researchers will compare the results of the AI group with the traditional group to see if both groups have similar success rates in performing anesthesia.

Participants will fast for 8 hours before the procedure, and drinking water will be prohibited for 2 hours after taking the intestinal purgatives.

Conditions

  • Anesthesia Induction

Interventions

PROCEDURE

AI Controlled General Anesthesia

During gastrointestinal endoscopy, anesthesia will be induced using ciprofol, and controlled by an AI model.

PROCEDURE

General Anesthesia (GA)

Anesthesia will be induced using ciprofol, and controlled by experienced anesthesiologists.

Sponsors & Collaborators

  • Zhengzhou Central Hospital

    collaborator OTHER
  • Xinzheng Public People's Hospital

    collaborator UNKNOWN
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Anxi County Hospital

    collaborator UNKNOWN
  • Jinjiang Municipal Hospital, Shanghai Sixth People's Hospital Fujian Campus

    collaborator UNKNOWN
  • Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2025-09-01
Completion
2025-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06857344 on ClinicalTrials.gov